title: Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach.
abstract: Mutation screening of the major autosomal dominant polycystic kidney disease gene (PKD1) has been complicated by the large transcript size (> 14 kb) and by reiteration of the genomic area encoding 75% of the protein on the same chromosome (the HG loci). The sequence similarity between the PKD1 and HG regions has precluded specific analysis of the duplicated region of PKD1, and consequently all previously described mutations map to the unique 3' region of PKD1. We have now developed a novel anchored reverse-transcription-PCR (RT-PCR) approach to specifically amplify duplicated regions of PKD1, employing one primer situated within the single-copy region and one within the reiterated area. This strategy has been incorporated in a mutation screen of 100 patients for more than half of the PKD1 exons (exons 22-46; 37% of the coding region), including 11 (exons 22-32) within the duplicated gene region, by use of the protein-truncation test (PTT). Sixty of these patients also were screened for missense changes, by use of the nonisotopic RNase cleavage assay (NIRCA), in exons 23-36. Eleven mutations have been identified, six within the duplicated region, and these consist of three stop mutations, three frameshifting deletions of a single nucleotide, two splicing defects, and three possible missense changes. Each mutation was detected in just one family (although one has been described elsewhere); no mutation hot spot was identified. The nature and distribution of mutations, plus the lack of a clear phenotype/genotype correlation, suggest that they may inactivate the molecule. RT-PCR/PTT proved to be a rapid and efficient method to detect PKD1 mutations (differentiating pathogenic changes from polymorphisms), and we recommend this procedure as a firstpass mutation screen in this disorder.
authors.affiliation: MRC Molecular Haematology Unit, John Radcliffe Hospital, Oxford, Headington, United Kingdom.
authors.forename: B
authors.initials: B
authors.lastname: Peral
authors.forename: V
authors.initials: V
authors.lastname: Gamble
authors.forename: C
authors.initials: C
authors.lastname: Strong
authors.forename: A C
authors.initials: AC
authors.lastname: Ong
authors.forename: J
authors.initials: J
authors.lastname: Sloane-Stanley
authors.forename: K
authors.initials: K
authors.lastname: Zerres
authors.forename: C G
authors.initials: CG
authors.lastname: Winearls
authors.forename: P C
authors.initials: PC
authors.lastname: Harris
mesh_terms: D000328:Adult; D017668:Age of Onset; D017398:Alternative Splicing; D000595:Amino Acid Sequence; D001483:Base Sequence; D002874:Chromosome Mapping; D017931:DNA Primers; D005091:Exons; D005260:Female; D006801:Humans; D007438:Introns; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D010375:Pedigree; D017354:Point Mutation; D016891:Polycystic Kidney, Autosomal Dominant / Q000235:genetics*; D016133:Polymerase Chain Reaction; D014176:Protein Biosynthesis; D011506:Proteins / Q000235:genetics*; D012091:Repetitive Sequences, Nucleic Acid; D017384:Sequence Deletion; D050396:TRPP Cation Channels; D014158:Transcription, Genetic
chemical_list: D017931:DNA Primers; D011506:Proteins; D050396:TRPP Cation Channels